Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fusion‐positive non‐small cell lung carcinoma: Biological principles, clinical practice, and diagnostic implications
Daniel Kazdal, Véronique Hofman, Petros Christopoulos, et al.
Genes Chromosomes and Cancer (2022) Vol. 61, Iss. 5, pp. 244-260
Closed Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group
M.F. Mosele, C. Benedikt Westphalen, A Stenzinger, et al.
Annals of Oncology (2024) Vol. 35, Iss. 7, pp. 588-606
Open Access | Times Cited: 68
EML4‐ALK biology and drug resistance in non‐small cell lung cancer: a new phase of discoveries
Mariam Elshatlawy, Josephina Sampson, K. Clarke, et al.
Molecular Oncology (2023) Vol. 17, Iss. 6, pp. 950-963
Open Access | Times Cited: 30
Current challenges and practical aspects of molecular pathology for non-small cell lung cancers
Paul Hofman, Sabina Berezowska, Daniel Kazdal, et al.
Virchows Archiv (2023) Vol. 484, Iss. 2, pp. 233-246
Open Access | Times Cited: 18
High‐throughput molecular assays for inclusion in personalised oncology trials – State‐of‐the‐art and beyond
Anders Edsjö, Hege G. Russnes, Janne Lehtiö, et al.
Journal of Internal Medicine (2024) Vol. 295, Iss. 6, pp. 785-803
Open Access | Times Cited: 5
Setting Up an Ultra-Fast Next-Generation Sequencing Approach as Reflex Testing at Diagnosis of Non-Squamous Non-Small Cell Lung Cancer; Experience of a Single Center (LPCE, Nice, France)
Marius Ilié, Véronique Hofman, Christophe Bontoux, et al.
Cancers (2022) Vol. 14, Iss. 9, pp. 2258-2258
Open Access | Times Cited: 25
Targeting MET in Non-Small Cell Lung Cancer (NSCLC): A New Old Story?
Calogera Claudia Spagnolo, Giuliana Ciappina, Elisa Giovannetti, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 10119-10119
Open Access | Times Cited: 13
Gene Fusion Detection in NSCLC Routine Clinical Practice: Targeted-NGS or FISH?
Lorenza Pecciarini, Emanuela Brunetto, Greta Grassini, et al.
Cells (2023) Vol. 12, Iss. 8, pp. 1135-1135
Open Access | Times Cited: 11
A comprehensive overview of the relationship between RET gene and tumor occurrence
Lu Zhao, Na Wang, Dou Zhang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 10
Case report: First evidence of impressive efficacy of modulated dose selpercatinib in a young Caucasian with ANK3-RET fusion-positive NSCLC
Elisa De Carlo, Elisa Bertoli, Mónica Schiappacassi, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 3
Patient Selection Approaches in FGFR Inhibitor Trials—Many Paths to the Same End?
Peter Ellinghaus, Daniel Neureiter, Hendrik Nogai, et al.
Cells (2022) Vol. 11, Iss. 19, pp. 3180-3180
Open Access | Times Cited: 16
Ultrafast Gene Fusion Assessment for Nonsquamous NSCLC
Véronique Hofman, Simon Heeke, Christophe Bontoux, et al.
JTO Clinical and Research Reports (2022) Vol. 4, Iss. 2, pp. 100457-100457
Open Access | Times Cited: 15
A narrative review of methods for the identification of ALK fusions in patients with non-small cell lung carcinoma
Susana Hernández, Esther Conde, Marta Alonso de la Varga, et al.
Translational Lung Cancer Research (2023) Vol. 12, Iss. 7, pp. 1549-1562
Open Access | Times Cited: 8
Expanding Broad Molecular Reflex Testing in Non-Small Cell Lung Cancer to Squamous Histology
Martin Zacharias, Selma Konjić, Nikolaus Kratochwill, et al.
Cancers (2024) Vol. 16, Iss. 5, pp. 903-903
Open Access | Times Cited: 2
Shifting from Immunohistochemistry to Screen for ALK Rearrangements: Real-World Experience in a Large Single-Center Cohort of Patients with Non-Small-Cell Lung Cancer
Marius Ilié, Samantha Goffinet, Guylène Rignol, et al.
Cancers (2024) Vol. 16, Iss. 12, pp. 2219-2219
Open Access | Times Cited: 2
Daily Practice Assessment of KRAS Status in NSCLC Patients: A New Challenge for the Thoracic Pathologist Is Right around the Corner
Christophe Bontoux, Véronique Hofman, Patrick Brest, et al.
Cancers (2022) Vol. 14, Iss. 7, pp. 1628-1628
Open Access | Times Cited: 12
Non-small-cell lung cancer: how to manage RET-positive disease
Elisa Andrini, Mirta Mosca, Linda Galvani, et al.
Drugs in Context (2022) Vol. 11, pp. 1-12
Open Access | Times Cited: 12
Targeted therapy of RET fusion-positive non-small cell lung cancer
Zixiong Shen, Binxu Qiu, Lin Li, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 12
Matched tissue and liquid biopsies for advanced non-small cell lung cancer patients A potentially indispensable complementary approach
Paul Hofman
Translational Oncology (2023) Vol. 35, pp. 101735-101735
Open Access | Times Cited: 7
Unveiling the Role of HGF/c-Met Signaling in Non-Small Cell Lung Cancer Tumor Microenvironment
Shuxi Yao, Xinyue Liu, Yanqi Feng, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 9101-9101
Open Access | Times Cited: 2
Molecular Profiling in Non-Squamous Non-Small Cell Lung Carcinoma: Towards a Switch to Next-Generation Sequencing Reflex Testing
Nina Pujol, Simon Heeke, Christophe Bontoux, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 10, pp. 1684-1684
Open Access | Times Cited: 11
Detecting ALK, ROS1, and RET fusions and the METΔex14 splicing variant in liquid biopsies of non‐small‐cell lung cancer patients using RNA‐based techniques
Ana Giménez‐Capitán, Estela Sánchez‐Herrero, Lucía Robado de Lope, et al.
Molecular Oncology (2023) Vol. 17, Iss. 9, pp. 1884-1897
Open Access | Times Cited: 6
Cuproptosis-related ceRNA axis triggers cell proliferation and cell cycle through CBX2 in lung adenocarcinoma
Jiang Wu, Guang Fu, Chao Luo, et al.
BMC Pulmonary Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Analysis on the pathogenesis and treatment progress of NRG1 fusion-positive non-small cell lung cancer
Hongyan Li, Lina Xu, Hongshun Cao, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Deciphering the Impact of HER2 Alterations on Non-Small-Cell Lung Cancer: From Biological Mechanisms to Therapeutic Approaches
Christophe Bontoux, Jonathan Benzaquen, Véronique Hofman, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 10, pp. 1651-1651
Open Access | Times Cited: 8
[Chinese Expert Consensus on the Clinical Practice of Non-small Cell Lung Cancer 
Fusion Gene Detection Based on RNA-based NGS].

PubMed (2023) Vol. 26, Iss. 11, pp. 801-812
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top